Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | vacuolar protein sorting 26 | 0.0392 | 0.1586 | 0.5 |
Entamoeba histolytica | membrane-bound O-acyltransferase (MBOAT ) family protein | 0.0392 | 0.1586 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0392 | 0.1586 | 0.5 |
Entamoeba histolytica | membrane-bound O-acyltransferase (MBOAT ) family protein | 0.0392 | 0.1586 | 0.5 |
Loa Loa (eye worm) | hhat protein | 0.0392 | 0.1586 | 0.1586 |
Brugia malayi | MBOAT family protein | 0.0392 | 0.1586 | 0.1586 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0392 | 0.1586 | 0.5 |
Trichomonas vaginalis | porcupine, putative | 0.0392 | 0.1586 | 0.5 |
Brugia malayi | MBOAT family protein | 0.0392 | 0.1586 | 0.1586 |
Leishmania major | glycerol uptake protein, putative | 0.0392 | 0.1586 | 0.5 |
Leishmania major | glycerol uptake protein, putative | 0.0392 | 0.1586 | 0.5 |
Trypanosoma cruzi | GUP1, putative | 0.0392 | 0.1586 | 0.5 |
Loa Loa (eye worm) | MBOAT family protein | 0.0392 | 0.1586 | 0.1586 |
Trypanosoma cruzi | glycerol uptake protein, putative | 0.0392 | 0.1586 | 0.5 |
Echinococcus multilocularis | diacylglycerol O acyltransferase 1 | 0.2333 | 1 | 1 |
Toxoplasma gondii | acyl-CoA:cholesterol acyltransferase alpha ACAT1-alpha | 0.2333 | 1 | 1 |
Leishmania major | glycerol uptake protein, putative | 0.0392 | 0.1586 | 0.5 |
Brugia malayi | Hhat protein | 0.0392 | 0.1586 | 0.1586 |
Loa Loa (eye worm) | hypothetical protein | 0.0392 | 0.1586 | 0.1586 |
Entamoeba histolytica | membrane-bound O-acyltransferase (MBOAT ) family protein | 0.0392 | 0.1586 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0392 | 0.1586 | 0.1586 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0392 | 0.1586 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0392 | 0.1586 | 0.1586 |
Trypanosoma cruzi | glycerol uptake protein, putative | 0.0392 | 0.1586 | 0.5 |
Brugia malayi | MBOAT family protein | 0.0392 | 0.1586 | 0.1586 |
Loa Loa (eye worm) | diacylglycerol acyltransferase | 0.2333 | 1 | 1 |
Leishmania major | glycerol uptake protein, putative | 0.0392 | 0.1586 | 0.5 |
Loa Loa (eye worm) | MBOAT family protein | 0.0392 | 0.1586 | 0.1586 |
Brugia malayi | MBOAT family protein | 0.0392 | 0.1586 | 0.1586 |
Trypanosoma brucei | glycerol uptake protein, putative | 0.0392 | 0.1586 | 0.5 |
Trypanosoma brucei | glycerol uptake protein, putative | 0.0392 | 0.1586 | 0.5 |
Trichomonas vaginalis | transmembrane protein nessy, putative | 0.0392 | 0.1586 | 0.5 |
Toxoplasma gondii | acyl-CoA:diacylglycerol acyltransferase 1-related enzyme | 0.2333 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0392 | 0.1586 | 0.5 |
Brugia malayi | MBOAT family protein | 0.0392 | 0.1586 | 0.1586 |
Echinococcus granulosus | diacylglycerol O acyltransferase 1 | 0.2333 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1941 | 0.83 | 0.83 |
Plasmodium falciparum | diacylglycerol O-acyltransferase | 0.2333 | 1 | 0.5 |
Loa Loa (eye worm) | membrane bound O-acyltransferase domain containing 1 | 0.0392 | 0.1586 | 0.1586 |
Onchocerca volvulus | 0.0392 | 0.1586 | 0.5 | |
Treponema pallidum | alginate O-acetylation protein (algI) | 0.0392 | 0.1586 | 0.5 |
Loa Loa (eye worm) | MBOAT family protein | 0.0392 | 0.1586 | 0.1586 |
Leishmania major | glycerol uptake protein, putative | 0.0392 | 0.1586 | 0.5 |
Trypanosoma cruzi | GUP1, putative | 0.0392 | 0.1586 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0392 | 0.1586 | 0.1586 |
Entamoeba histolytica | hypothetical protein | 0.0392 | 0.1586 | 0.5 |
Plasmodium vivax | diacylglycerol O-acyltransferase, putative | 0.2333 | 1 | 0.5 |
Schistosoma mansoni | diacylglycerol O-acyltransferase 1 | 0.2333 | 1 | 1 |
Loa Loa (eye worm) | hhat protein | 0.0392 | 0.1586 | 0.1586 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0392 | 0.1586 | 0.5 |
Trypanosoma cruzi | glycerol uptake protein, putative | 0.0392 | 0.1586 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.